Stocks Special Reports LICs Credit Funds ETFs Tools SMSFs
Video Archive Article Archive
News Stocks Special Reports Funds ETFs Features SMSFs Learn

Company News Summary

Acrux Announces Allowance of Underarm Administration Patent in US

12 Feb 2013  |  10:19:00  |  Associate analysts  |  Increase  |  Decrease  |  

Original announcement: Allowance of underarm administration patent in United States

Acrux confirmed that its patent application concerning the underarm administration of testosterone formulations has been allowed by the US Patent and Trademark Office (USPTO). The patent is expected to grant following payment of the issue fee. The USPTO's preliminary calculation of patent term adjustment is one additional year beyond the expiry date of June 2026. This will be re-calculated when the patent grants. A similar patent was previously granted in Australia, NZ, Singapore and South Africa and applications are under examination in a number of other countries around the world.

Please click here for full details

See more ASX300 News Announcements